Dark
Light
System
Institutional Investment Manager
Broadfin Capital, LLC
Broadfin Capital, LLC (CIK: 0001511901) incorporated in Delaware, located at 300 Park Avenue, 25th Floor, New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q4)
Portfolio Summary: 88 holdings with a total value of $1,625,830,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 HORIZON PHARMA PLC 8,131,310 176,205,000 10.84%
2 ISHARES TR 1,150,000 129,513,000 7.97% Put
3 VALEANT PHARMACEUTICALS INTL 900,000 91,485,000 5.63%
4 NEVRO CORP 1,201,480 81,112,000 4.99%
5 SPDR SER TR 1,000,000 70,200,000 4.32% Put
6 HERON THERAPEUTICS INC 2,232,001 59,594,000 3.67%
7 RETROPHIN INC COM 2,959,790 57,094,000 3.51%
8 PROGENICS PHARMACEUTICALS IN 8,951,169 54,871,000 3.37%
9 FLAMEL TECHNOLOGIES SA SPONSORED ADR 4,394,464 53,656,000 3.30%
10 NOVADAQ TECHNOLOGIES INC 3,683,013 46,922,000 2.89%
11 AEGERION PHARMACEUTICALS INC 3,510,291 35,454,000 2.18%
12 LA JOLLA PHARMACEUTICAL CO 1,165,373 31,465,000 1.94%
13 ANGIODYNAMICS INC 2,498,527 30,332,000 1.87%
14 IGNYTA INC COM 2,256,546 30,238,000 1.86%
15 EMERGENT BIOSOLUTIONS INC COM 672,922 26,924,000 1.66%
16 BioDelivery Sciences International Inc 4,688,794 22,459,000 1.38%
17 TELIGENT INC NEW 2,287,728 20,361,000 1.25%
18 ARATANA THERAPEUTICS INC COM 3,428,865 19,133,000 1.18%
19 SOCIETAL CDMO INC 2,060,086 18,541,000 1.14%
20 MEDGENICS INC 3,045,306 18,333,000 1.13%
21 ATRICURE INC 803,519 18,031,000 1.11%
22 PERNIX THERAPEUTICS HLDGS IN 6,090,829 17,968,000 1.11%
23 SEASPINE HLDGS CORP COM 1,000,007 17,180,000 1.06%
24 ADVAXIS INC COM NEW 1,690,517 17,007,000 1.05%
25 Lion Biotechnologies 2,105,519 16,255,000 1.00%
26 ZOGENIX INC 1,087,112 16,024,000 0.99%
27 DYNAVAX TECHNOLOGIES CORP 629,710 15,214,000 0.94%
28 CORIUM INTERNATIONAL INC 1,802,092 14,633,000 0.90%
29 AMPHASTAR PHARMACEUTICALS IN COM 1,026,979 14,614,000 0.90%
30 KEMPHARM INC 732,338 14,544,000 0.89%
31 ANTARES PHARMA INC 11,475,000 13,885,000 0.85%
32 DEPOMED INC 725,600 13,155,000 0.81%
33 RAPTOR PHARMACEUTICAL CORP 2,412,995 12,548,000 0.77%
34 Egalet Corp 1,134,750 12,505,000 0.77%
35 ST JUDE 200,000 12,354,000 0.76%
36 QLT INC 4,445,527 11,825,000 0.73%
37 DERMA SCIENCES INC COM PAR .01 2,562,104 11,709,000 0.72%
38 Strongbridge Biopharma plc 1,656,705 10,911,000 0.67%
39 HORIZON PHARMA PLC 500,000 10,835,000 0.67% Call
40 Redhill Biopharma Ltd 829,906 10,689,000 0.66%
41 TREVENA INC 1,000,000 10,500,000 0.65%
42 CATALYST PHARMACEUTICALS INC 4,183,177 10,249,000 0.63%
43 VALEANT PHARMACEUTICALS INTL 100,000 10,165,000 0.63% Call
44 PARATEK PHARMACEUTICALS INC 530,283 10,059,000 0.62%
45 ENDOLOGIX INC 1,000,000 9,900,000 0.61%
46 ALCOBRA LTD 1,557,106 9,779,000 0.60%
47 IDERA PHARMACEUTICALS INC 3,094,745 9,563,000 0.59%
48 RIGEL PHARMACEUTICAL INC 3,125,282 9,470,000 0.58%
49 AMAG PHARMACEUTICALS INC COM 300,000 9,057,000 0.56%
50 PERNIX THERAPEUTICS HLDGS IN 15,500,000 8,944,000 0.55%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-16-010850, filed 2016.02.16).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.